GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Marinomed Biotech AG (WBO:MARI) » Definitions » 12-1 Month Momentum %

Marinomed Biotech AG (WBO:MARI) 12-1 Month Momentum % : -74.52% (As of Dec. 12, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Marinomed Biotech AG 12-1 Month Momentum %?

12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2024-12-12), Marinomed Biotech AG's 12-1 Month Momentum % is -74.52%.

The industry rank for Marinomed Biotech AG's 12-1 Month Momentum % or its related term are showing as below:

WBO:MARI's 12-1 Month Momentum % is ranked worse than
90.42% of 1441 companies
in the Biotechnology industry
Industry Median: -13.28 vs WBO:MARI: -74.52

Competitive Comparison of Marinomed Biotech AG's 12-1 Month Momentum %

For the Biotechnology subindustry, Marinomed Biotech AG's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Marinomed Biotech AG's 12-1 Month Momentum % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Marinomed Biotech AG's 12-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Marinomed Biotech AG's 12-1 Month Momentum % falls into.



Marinomed Biotech AG  (WBO:MARI) 12-1 Month Momentum % Calculation

12-1 Month Momentum % is calculated as following:

12-1 Month Momentum %=( Price 1-month ago / Price 12-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Marinomed Biotech AG  (WBO:MARI) 12-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Marinomed Biotech AG 12-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Marinomed Biotech AG's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Marinomed Biotech AG Business Description

Traded in Other Exchanges
Address
Hovengasse 25, Korneuburg, AUT, 2100
Marinomed Biotech AG is a biopharmaceutical company focusing on the development of products in the field of respiratory and ophthalmological diseases. The products marketed by the company are based on its platform Carragelose and Marinosolv. The company develops products for cough, cold, influenza, allergic rhinitis, and ophthalmic diseases. Its product offerings include virus-blocking nasal sprays, virus-blocking decongestant nasal sprays, virus-blocking lozenges, and virus-blocking throat sprays. The company has two reportable segments which are Virology, Immunology, and other, the majority of revenue generated from the virology segment.
Executives
Simon Nebel Supervisory Board
Andreas Grassauer Board of Directors
Eva Prieschl-grassauer Board of Directors

Marinomed Biotech AG Headlines

No Headlines